Whitepapers
Have you written a paper on a specific application method, or perhaps researched a peculiar condition? Share with your fellow veterinarians and submit your own papers here!
.pdf
file
(613.52 KB)
WBCs were responsible for the transport and release
of 14C-ENR at sites of inflammation. Accumulation of drug by WBCs might increase the concentration of drug at the site of infection, thus facilitating therapeutic success.
Boothe et al
March 12, 2010
Tags
dog
inflamed tissues
Category Application method
.pdf
file
(258.34 KB)
Optimising antimicrobial therapy – the MPC as a strategy to minimise antibiotic resistance
Bayer AG
March 12, 2010
Tags
Mutant Prevention Concentration
Category Pest
.pdf
file
(520.37 KB)
Current measurements of antimicrobial susceptibility or resistance utilize a standardized bacterial inoculum (105 cfu ⁄ mL) exposed to varying drug concentrations in a test tube. Following incubation under ideal conditions, the lowest drug concentration inhibiting
growth is the minimum inhibitory concentration (MIC).
Joseph M. Blondeau
March 12, 2010
Tags
Veterinary Dermatology
2009
Category Pest
.pdf
file
(2.90 MB)
In 2009, Muller et al published the results of a large study that examined the susceptibility of bacterial isolates from dogs and cats to the fluoroquinolone antimicrobials Enrofloxacin (Baytril) and Marbofloxacin.
Elisabeth Müller
March 10, 2010
Category Condition
.pdf
file
(919.13 KB)
In 2009, Muller et al published the results of a large study that examined the susceptibility of bacterial isolates from dogs and cats to the fluoroquinolone antimicrobials Enrofloxacin (Baytril) and Marbofloxacin. This Technical Update examines the study, the results and the implications for the use of these important therapeutic agents in clinical practice.
Bayer AG
March 12, 2010
Tags
Muller
dog
cat
study
Category Condition